Mitsubishi Chemical`s clinical study effectiveness of probiotic on intestinal
01 Sep 2024 //
INDIANPHARMAPOST
Mitsubishi Published Study regarding Effect of Ingestion of Cysteine Peptide
12 Mar 2024 //
BUSINESSWIRE
Yield10 & Mitsubishi Sign MOU to Evaluate Partnership to Supply Biofuel
11 Jan 2023 //
GLOBENEWSWIRE
Takeda, IIF, and Mitsubishi further develop Shonan iPark in Japan
22 Dec 2022 //
BIOSPECTRUMASIA
PeptiGrowth Inc. is Launching A Novel Synthetic Peptide BMP4,7 inhibitor (Noggin-like peptide)
30 Jun 2022 //
PRESS RELEASE
Mitsubishi Granted New US Patent for "Composition containing glutathione"
22 Feb 2022 //
BUSINESSWIRE
Cryoport and Mitsubishi Logistics Corporation Partner
25 Aug 2021 //
CONTRACTPHARMA
Mitsubishi`s air purification technology potentially inactivates SARS-CoV-2
10 Feb 2021 //
BIOSPECTRUMASIA
Mitsubishi Tanabe Pharma America to Present Real-World Data on RADICAVA
04 Dec 2019 //
PR NEWSWIRE
Mitsubishi Corp to invest Rs 100 crore in Sastasundar Healthbuddy
26 Aug 2019 //
ECONOMICTIMES
Promethera Raises Euro 10M in a Series C-extension Financing
28 Oct 2016 //
BUSINESS WIRE
Mitsubishi backs Aurobindo, Intas for Teva asset bid
05 Oct 2016 //
BUSINESS-STANDARD
Japanese company loses patent bid for diabetes drug
14 Dec 2015 //
ECONOMIC TIMES
Japan`s Mitsubishi Tanabe pharma to revamp operations
28 Jul 2015 //
BIOSPECTRUM ASIA